RESUMEN
Primary Sjögren's syndrome (pSS) is a chronic inflammatory autoimmune disease with an unclear pathogenesis, and there is currently no approved drug for the treatment of this disease. Iguratimod, as a novel clinical anti-rheumatic drug in China and Japan, has shown remarkable efficacy in improving the symptoms of patients with pSS in clinical studies. In this study we investigated the mechanisms underlying the therapeutic effect of iguratimod in the treatment of pSS. Experimental Sjögren's syndrome (ESS) model was established in female mice by immunizing with salivary gland protein. After immunization, ESS mice were orally treated with iguratimod (10, 30, 100 mg·kg-1·d-1) or hydroxychloroquine (50 mg·kg-1·d-1) for 70 days. We showed that iguratimod administration dose-dependently increased saliva secretion, and ameliorated ESS development by predominantly inhibiting B cells activation and plasma cell differentiation. Iguratimod (30 and 100 mg·kg-1·d-1) was more effective than hydroxychloroquine (50 mg·kg-1·d-1). When the potential target of iguratimod was searched, we found that iguratimod bound to TEC kinase and promoted its degradation through the autophagy-lysosome pathway in BAFF-activated B cells, thereby directly inhibiting TEC-regulated B cells function, suggesting that the action mode of iguratimod on TEC was different from that of conventional kinase inhibitors. In addition, we found a crucial role of TEC overexpression in plasma cells of patients with pSS. Together, we demonstrate that iguratimod effectively ameliorates ESS via its unique suppression of TEC function, which will be helpful for its clinical application. Targeting TEC kinase, a new regulatory factor for B cells, may be a promising therapeutic option.
Asunto(s)
Diferenciación Celular , Cromonas , Células Plasmáticas , Proteínas Tirosina Quinasas , Síndrome de Sjögren , Sulfonamidas , Animales , Síndrome de Sjögren/tratamiento farmacológico , Femenino , Diferenciación Celular/efectos de los fármacos , Ratones , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Proteínas Tirosina Quinasas/metabolismo , Células Plasmáticas/efectos de los fármacos , Cromonas/farmacología , Cromonas/uso terapéutico , Sulfonamidas/farmacología , Sulfonamidas/uso terapéutico , Benzofuranos/farmacología , Benzofuranos/uso terapéutico , Hidroxicloroquina/farmacología , Hidroxicloroquina/uso terapéutico , Modelos Animales de Enfermedad , Humanos , Linfocitos B/efectos de los fármacos , Linfocitos B/metabolismo , Antirreumáticos/farmacología , Antirreumáticos/uso terapéuticoRESUMEN
Truncation of tau protein is considered an early event in Alzheimer's disease (AD) and is believed to play a major pathogenic role in sporadic AD. However, causative factors that trigger tau truncation in AD remain poorly understood. In the present study, we demonstrate that CXCL1 (C-X-C motif ligand 1), a specific ligand for the chemokine receptor CXCR2, induced cleavage of tau at ASP421 in a caspase-3-dependent manner in long-term but not short-term cultured neurons. The cleaved tau formed varicosities or bead-like structures along the neurites, an abnormal distribution of tau induced by CXCL1 that has not been observed previously. CXCL1-induced activation of GSK3ß and the subsequent phosphorylation of tau preceded and were required for caspase-3 activation and tau cleavage. Moreover, intrahippocampal microinjection of lentiviral CXCL1 induced tau cleavage in hippocampal neurons in aged (15-18 months of age) but not adult mice (5-10 months of age). Our data highlight a new role of CXCR2 in tau cleavage and suggest that targeting CXCR2 may offer therapeutic benefits to patients with AD and potentially other tauopathies.
Asunto(s)
Envejecimiento , Caspasa 3/metabolismo , Quimiocina CXCL1/farmacología , Hipocampo/citología , Neuronas/efectos de los fármacos , Proteínas tau/metabolismo , Animales , Células Cultivadas , Quimiocina CXCL1/sangre , Quimiocina CXCL1/líquido cefalorraquídeo , Quimiocina CXCL1/genética , Embrión de Mamíferos , Femenino , Ratones , Ratones Endogámicos C57BL , Microinyecciones , Proteínas Asociadas a Microtúbulos/metabolismo , Mutación/genética , Neuronas/metabolismo , Embarazo , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Transfección , Proteínas tau/genéticaRESUMEN
It is widely accepted that brain derived neurotrophic factor (BDNF) plays a crucial role in mediating changes in learning and memory performance induced by environmental conditions. In order to ascertain whether BDNF modulates environmentally induced changes in exploratory behaviour, we examined mice carrying a deletion in one copy of the BDNF gene. Young heterozygous male BDNF knockout mice (BDNF+/-) and their wild-type (WT) controls were exposed to the enriched environment condition (EC) or the standard condition (SC) for 8 weeks. Exploratory behaviour was assessed in the open-field (OF) and hole-board (HB) test. Brains from EC and SC reared animals were processed for Golgi-Cox staining and the dendritic spine density in the dentate gyrus (DG) and CA1 hippocampal regions were examined. We found behavioural differences both due to the genetic modification and the environmental manipulation, with the BDNF+/- mice being more active in the OF whereas the EC mice had increased exploratory behaviour in the HB test. Environmental enrichment also led to an increase in dendritic spines in the hippocampal CA1 region and DG of the wild-type mice. This effect was also found in the enriched BDNF+/- mice, but was less pronounced. Our findings support the critical role of BDNF in behavioural and neural plasticity associated with environmental enrichment and suggest that besides maze learning performance, BDNF dependent mechanisms are also involved in other aspects of behaviour. Here we provide additional evidence that exploratory activity is influenced by BDNF.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/fisiología , Conducta Exploratoria/fisiología , Actividad Motora/fisiología , Análisis de Varianza , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Espinas Dendríticas/fisiología , Giro Dentado/citología , Giro Dentado/fisiología , Ambiente , Heterocigoto , Hipocampo/citología , Hipocampo/fisiología , Vivienda para Animales , Masculino , Ratones , Ratones Noqueados , Neuronas/citología , Neuronas/fisiologíaRESUMEN
In the search for animal models of human geriatric depression, we found that operant extinction of escape from water results in the expression of immobility in different age groups, indicative of behavioral "despair", which was also associated with the resistance-to-extinction (RTE) expressed by these animals. With respect to the neurotrophin hypothesis of depression, nerve-growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) protein levels in frontal cortex (FC) and hippocampus (HP) were examined and related to behavioral immobility and RTE in the water maze in aged and adult Wistar rats. Age-related increases in levels of NGF were found in HP and of NT-3 in FC. Indices of immobility showed relationships in the aged with NGF and, in adults, with BDNF, pointing to a dissociation of neurotrophic involvement in extinction trial-induced "despair" in aged and adult rats. The present results support the hypothesis, that extinction-induced immobility in the water maze reflects a state akin to behavioral despair and point to age-related differences of neurotrophic involvement in depressive-like symptoms. The concept of extinction-induced behavioral "despair" in the aged subsumes several aspects of human geriatric depression, such as co-morbidity of learning impairment and anxiety, and, thus could represent a useful paradigm to examine the neuronal mechanisms underlying depression, especially in aged rodents.
Asunto(s)
Envejecimiento/metabolismo , Depresión/metabolismo , Extinción Psicológica/fisiología , Lóbulo Frontal/metabolismo , Hipocampo/metabolismo , Factores de Crecimiento Nervioso/metabolismo , Envejecimiento/psicología , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Condicionamiento Operante/fisiología , Modelos Animales de Enfermedad , Reacción de Fuga/fisiología , Pérdida de Tono Postural/fisiología , Masculino , Factor de Crecimiento Nervioso/metabolismo , Neurotrofina 3/metabolismo , Ratas , Ratas Wistar , Refuerzo en Psicología , Estadísticas no ParamétricasRESUMEN
Some epidemiological studies concerning gender differences in Alzheimer's disease (AD) support the higher prevalence and incidence of AD in women, while most studies using animal models of aging have included only male subjects. It is still uncommon for aged males and females to be compared in the same study. In the present study, we investigated how age and gender influence the excitotoxic neurodegeneration by treating C57BL/6 mice (aged females and males as well as adult females and males) with kainic acid (KA) intranasally. Clinical signs, behavioural changes, pathological changes and astrocyte proliferation were tested; and the levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were measured after KA treatment. The results showed that aged female mice were more sensitive to KA-induced excitotoxicity as demonstrated by severer seizure activity, increased locomotion and rearing in open-field test, prominent hippocampal neuronal damage, enhanced astrocyte proliferation compared with aged males, adult females and adult male mice. In addition, higher BDNF level in hippocampus of aged female mice was observed. These results denote the disparity of aging and gender in KA-induced hippocampal neurodegeneration and aged female mice are more sensitive to the excitotoxicity.
Asunto(s)
Envejecimiento/fisiología , Agonistas de Aminoácidos Excitadores/toxicidad , Ácido Kaínico/toxicidad , Degeneración Nerviosa/inducido químicamente , Animales , Astrocitos/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Proliferación Celular/efectos de los fármacos , Corteza Cerebral/patología , Ensayo de Inmunoadsorción Enzimática , Femenino , Proteína Ácida Fibrilar de la Glía/metabolismo , Hipocampo/patología , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Actividad Motora/efectos de los fármacos , Degeneración Nerviosa/patología , Factores de Crecimiento Nervioso/metabolismo , Convulsiones/inducido químicamente , Convulsiones/patología , Caracteres SexualesRESUMEN
Environmental enrichment condition (EC) induces profound behavioural, neurochemical and neuroanatomical changes. Increasing evidence has shown that the hippocampus, which is implicated in a range of cognitive functions, including learning and memory, is one of the most susceptible brain areas to the effects of enriched rearing. Recent work also suggests that the hippocampus is functionally segregated; lesion studies have shown that the dorsal hippocampus is important for spatial learning, whereas the ventral part is critical in emotional behaviour in rats. We investigated the effects of differential housing environments on anxiety-related behaviour and neurotrophin levels in dorsal and ventral hippocampus, and other brain regions. Ninety-six male and female C57BL/6 mice were reared in EC or standard housing condition (SC) for 4 months after weaning. Thereafter sixty-four animals were tested in the elevated plus-maze, open-field, novel-objects exploration and food neophobia. Thirty-two animals remained as untested. Subsequently, brain nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) were analysed in selected brain regions of the tested and non-tested animals. Differential housing influenced anxiety-related behaviour in the plus-maze and brain neurotrophins. Baseline levels of BDNF and NGF protein were differently distributed in dorsal and ventral parts of hippocampus in both male and female mice, with levels in the dorsal hippocampal being consistently higher than those in ventral hippocampus. Exposure to behavioural testing induced complex changes on neurotrophin levels in selected brain regions. This study demonstrates for the first time the differential distribution of normal levels of neurotrophin protein in dorsal and ventral hippocampus in mice, and these levels can be affected by environmental enrichment and have an impact on emotional behaviour.
Asunto(s)
Ansiedad/metabolismo , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Ambiente , Conducta Exploratoria/fisiología , Hipocampo/metabolismo , Factor de Crecimiento Nervioso/metabolismo , Análisis de Varianza , Animales , Femenino , Vivienda para Animales , Masculino , Ratones , Ratones Endogámicos C57BL , Factores Sexuales , Estadísticas no Paramétricas , Estrés Psicológico/metabolismo , Distribución TisularRESUMEN
This study assessed the effects of intermittent individual housing on behaviour and brain neurotrophins, and whether physical exercise could influence alternate individual-housing-induced effects. Five-week-old BALB/c mice were either housed in enhanced social (E) or standard social (S) housing conditions for 2 weeks. Thereafter they were divided into six groups and for 6 weeks remained in the following experimental conditions: Control groups remained in their respective housing conditions (E-control, S-control); enhanced individual (E-individual) and standard individual (S-individual) groups were exposed every other day to individual cages without running-wheels; enhanced running-wheel (E-wheel) and standard running-wheel (S-wheel) groups were put on alternate days in individual running-wheel cages. Animals were assessed for activity in an automated individual cage system (LABORAS) and brain neurotrophins analysed. Intermittent individual housing increased behavioural activity and reduced nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in frontal cortex; while it increased BDNF level in the amygdala and BDNF protein and mRNA in hippocampus. Besides normalizing motor activity and regulating BDNF and NGF levels in hippocampus, amygdala and cerebellum, physical exercise did not attenuate reduction of cortical NGF and BDNF induced by intermittent individual housing. This study demonstrates that alternate individual housing has significant impact on behaviour and brain neurotrophin levels in mice, which can be partially altered by voluntary physical exercise. Our results also suggest that some changes in neurotrophin levels induced by intermittent individual housing are not similar to those caused by continuous individual housing.
Asunto(s)
Conducta Animal/fisiología , Encéfalo/metabolismo , Factores de Crecimiento Nervioso/metabolismo , Condicionamiento Físico Animal/fisiología , Aislamiento Social , Análisis de Varianza , Animales , Encéfalo/anatomía & histología , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Ensayo de Inmunoadsorción Enzimática/métodos , Hibridación in Situ/métodos , Locomoción/fisiología , Masculino , Ratones , Ratones Endogámicos BALB C , Factor de Crecimiento Nervioso/genética , Factor de Crecimiento Nervioso/metabolismo , Factores de Crecimiento Nervioso/genética , Carrera/fisiologíaRESUMEN
Experimental autoimmune neuritis (EAN), an acute demyelinating inflammatory disease of the peripheral nervous system (PNS), is a good model for the human counterpart, Guillain-Barré syndrome. Apolipoprotein E (ApoE), a 34 kDa glycosylated protein with multiple biological properties, has been linked both with the innate immune response of mice and with neurological disease. The present study investigated the previously unexplored role of ApoE in autoimmune-mediated demyelination. ApoE-deficient (apoE -/-) mice exhibited a greater susceptibility to EAN induced by the PNS myelin P0 protein peptide 180-199, as compared to wild type (apoE +/+) mice. The augmented susceptibility seen in apoE -/- mice was associated with increased inflammatory cell infiltrates in the PNS during the effector phase. Although the 2 groups of mice exhibited no quantitative or proportional differences in splenic lymphocyte populations, the apoE -/- mice showed enhanced antigen-specific proliferation of T cells of spleen, which is related to modified macrophage function, upregulation of Th1 and downregulation of Th2-autoreactive responses to P0 peptide. These effects were shown as increased numbers of IFN-gamma expressing cells in the spleen and of IFN-gamma, IL-12 and TNF-alpha expressing cells in the PNS, as well as a decreased IL-10 production by splenic cells in apoE -/- mice. In addition, apoE -/- mice had enhanced antigen-specific antibody responses, which might have contributed to their aggravated EAN. These data provide strong evidence that apoE acts as an inhibitor of this inflammatory and demyelinating disease by upregulating IL-10, as well as by inhibiting Th1 responses and antigen-specific antibody formation. These data may aid the development of new and more effective therapeutic strategies for inflammatory and demyelinating diseases such as Guillain-Barré syndrome.
Asunto(s)
Apolipoproteínas E/metabolismo , Activación de Linfocitos/inmunología , Proteína P0 de la Mielina/metabolismo , Neuritis Autoinmune Experimental/inmunología , Neuritis Autoinmune Experimental/metabolismo , Linfocitos T/inmunología , Análisis de Varianza , Animales , Antígenos/metabolismo , Apolipoproteínas E/deficiencia , Apolipoproteínas E/genética , Recuento de Células , Citocinas/metabolismo , Susceptibilidad a Enfermedades , Ensayo de Inmunoadsorción Enzimática/métodos , Citometría de Flujo/métodos , Inmunoglobulina G/análisis , Inmunoglobulina G/metabolismo , Inmunohistoquímica/métodos , Inflamación , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neuritis Autoinmune Experimental/patología , Infiltración Neutrófila , Nervios Periféricos/inmunología , Nervios Periféricos/patología , Bazo/citología , Bazo/inmunología , Bazo/metabolismo , Linfocitos T/metabolismo , Factores de Tiempo , Regulación hacia ArribaRESUMEN
Kainic acid (KA)-induced hippocampal injury is a good model for studying human neurodegenerative diseases. To investigate the roles of immune cells and age related changes in neurodegeneration, we used this model to assess reactions in young and middle-aged wild-type and CD4/CD8(-/-) mice by intranasal administration of KA. We found that CD4/CD8-deficiency resulted in a significant reduction of the severity of clinical signs and pathological changes in KA-treated young, but not in KA-treated middle-aged mice. Middle-aged wild-type mice had a similar reaction to KA insult as young and middle-aged CD4/CD8(-/-) mice. CD4/CD8(-/-) mice exhibited decreased locomotor and rearing activities as they approached to middle-aged state, which was not seen in wild-type mice. In addition, CD4/CD8-deficiency and increased age prevented KA-induced increase of both locomotor and rearing activities. The results suggest that a decline of immunological function is associated with aging, and both of them may contribute to the relative resistance to KA-induced neurotoxicity.
Asunto(s)
Envejecimiento/inmunología , Antígenos CD4/genética , Linfocitos T CD4-Positivos/efectos de los fármacos , Antígenos CD8/genética , Linfocitos T CD8-positivos/efectos de los fármacos , Ácido Kaínico/toxicidad , Linfopenia/genética , Linfopenia/inmunología , Envejecimiento/efectos de los fármacos , Envejecimiento/genética , Animales , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Actividad Motora/efectos de los fármacos , Actividad Motora/genética , Actividad Motora/inmunologíaRESUMEN
Interleukin 12 (IL-12) is a proinflammatory cytokine with important immunoregulatory activities and is critical in determining the differentiation and generation of Th1 cells. For the present study, we investigated the role of endogenous IL-12 in the pathogenesis of experimental autoimmune neuritis (EAN), which is a CD4+ T-cell mediated autoimmune inflammatory disease of the peripheral nervous system. EAN is used as an animal model for Guillain-Barré syndrome of humans. Here, EAN was established in IL-12 p40 deficient mutant (IL-12-/-) C57BL/6 mice by immunization with P0 peptide 180-199, a purified component of peripheral nerve myelin, and Freund's complete adjuvant. In these IL-12-/- mice the onset of clinical disease was delayed, and the incidence and severity of EAN were significantly reduced compared to that in wild-type mice.The former group's clinical manifestations were associated with less P0-peptide 180-199 induced secretion of interferon-gamma (IFN-gamma) by splenocytes in vitro and low production of anti-P0-peptide 180-199 IgG2b antibodies in serum. Fewer IFN-gamma and TNF-alpha producing cells, but more cells secreting IL-4, were found in sciatic nerve sections from IL-12-/- mice, consistent with impaired Th1 functions and response. However, the IL-12 deficiency appeared not to affect P0 peptide 180-199-specific T-cell proliferation. These results indicate that IL-12 has a major role in the initiation, enhancement and perpetuation of pathogenic events in EAN by promoting a Th1 cell-mediated immune response and suppressing the Th2 response. This information augments consideration of IL-12 as a therapeutic target in Guillain-Barré syndrome and other T-cell-mediated autoimmune diseases.
Asunto(s)
Síndrome de Guillain-Barré/inmunología , Mediadores de Inflamación/inmunología , Interleucina-12/deficiencia , Interleucina-12/inmunología , Neuritis Autoinmune Experimental/inmunología , Nervios Periféricos/inmunología , Subunidades de Proteína/deficiencia , Subunidades de Proteína/inmunología , Animales , Anticuerpos/sangre , Anticuerpos/inmunología , Quimiotaxis de Leucocito/genética , Quimiotaxis de Leucocito/inmunología , Citocinas/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Síndrome de Guillain-Barré/metabolismo , Síndrome de Guillain-Barré/fisiopatología , Inmunohistoquímica , Mediadores de Inflamación/metabolismo , Interleucina-12/genética , Subunidad p40 de la Interleucina-12 , Ratones , Ratones Noqueados , Proteína P0 de la Mielina/inmunología , Proteína P0 de la Mielina/farmacología , Vaina de Mielina/genética , Vaina de Mielina/inmunología , Neuritis Autoinmune Experimental/metabolismo , Neuritis Autoinmune Experimental/fisiopatología , Nervios Periféricos/metabolismo , Nervios Periféricos/fisiopatología , Subunidades de Proteína/genética , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Células TH1/inmunología , Células TH1/metabolismo , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
This study analyzes the impact of environmental complexity in adult rats on their emotional behavior and c-Fos expression (a transcription factor protein implicated in neuronal plasticity) in various subdivisions of amygdala, as well as selected parts of the thalamus and hypothalamus. The animals were housed for 60 days in either enriched or impoverished conditions and then one group of rats was tested in an open field test, and a second group of rats was treated to footshock-motivated aversive training. Two and 24 h later, the animals from the second group, along with the appropriate controls, were sacrificed and their brains were used for the immunocytochemical analysis of c-Fos levels. We found that this long-term environmental manipulation exerts significant effects on animals' emotionality and this behavioral difference is accompanied by the differential c-Fos activation (at 2 h after the aversive training) in the amygdala, a brain structure believed to subserve emotional reactions. On the other hand, no difference was found in c-Fos expression between both groups of animals in the thalamus and hypothalamus. At 24 h after the training, c-Fos levels were down to the values observed in naive rats that did not differentiate between enriched versus impoverished breeding conditions. These results may help to explain differential emotional aspects of behavior that arise following differential housing conditions of adult animals.
Asunto(s)
Amígdala del Cerebelo/metabolismo , Reacción de Prevención , Condicionamiento Clásico , Ambiente Controlado , Proteínas Proto-Oncogénicas c-fos/metabolismo , Animales , Reacción de Prevención/fisiología , Conducta Animal , Condicionamiento Clásico/fisiología , Regulación de la Expresión Génica , Hipotálamo/metabolismo , Inmunohistoquímica , Locomoción , Masculino , Ratas , Ratas Sprague-Dawley , Tálamo/metabolismoRESUMEN
Experimental autoimmune neuritis (EAN) is a demyelinating disease of the peripheral nervous system (PNS). This acute inflammatory disease is mediated by CD4+ T cells and bears significant similarities to the Guillain-Barré syndrome of humans. In the present study, we investigated the function of IL-18 in T cell-mediated autoimmunity of EAN in mice induced by P0 peptide 180-199 and Freund's complete adjuvant. Our data indicate that in 2 different therapeutic regimens, anti-IL-18 monoclonal antibody (mAb) effectively ameliorates the clinical and pathological signs of EAN. The suppression is associated with reduced inflammatory cell infiltration into the PNS and an insufficiency of autoreactive Th1 cells, as reflected by a reduced mononuclear cell proliferation and IFN-gamma-secretion in the spleen. Increased numbers of IL-4 expressing cells and decreased numbers of IFN-gamma and TNF-alpha expressing cells were found in the PNS. Our results suggest that shifting the Th1/Th2 balance towards Th2 cells may be one mechanism underlying EAN suppression by anti-IL-18 mAb. In addition, anti-IL-18 mAb treatment reduced anti-P0 peptide 180-199 autoantibody responses, which may also contribute to EAN suppression. We conclude that endogenous IL-18 plays a critical role in the pathogenesis of autoimmune demyelinating disease of the PNS and that IL-18 antagonists may provide a new therapy for these diseases.